Back

Cardiac resynchronization therapy and clinical outcomes in patients with advanced left ventricular dysfunction and a wide QRS

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Hot topics in device therapy Device Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Gregory Golovchiner

Rabin Medical Centre, Petah Tikva (Israel)

6 More presentations in this session

Presentation thumbnail
Real-world radiotherapy and healthcare utilization in patients implanted with cardiac implantable electronic devices
Mr L. Higuera (Mounds View, US)
Abstract Slides Video
Presentation thumbnail
ICD therapy in patients with preserved LVEF and monomorphic VT
Doctor S. Vakilzadeh-Hashemi (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Implantable cardioverter-defibrillator therapy compared to amiodarone in Chagas cardiomyopathy: a systematic review and meta-analysis
Doctor M. Chacon Quiros (San Jose, CR)
Abstract Slides Video
Presentation thumbnail
Comparison of long-term outcomes between left bundle branch-optimized cardiac resynchronization therapy and conventional biventricular pacing in cardiac resynchronization therapy upgrades
Doctor K. Misonou (Kitakyushu, JP)
Abstract Slides Video
Presentation thumbnail
Clinical impact of late phase responder in cardiac resynchronization therapy
Doctor Y. Kitami (Suita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Hot topics in device therapy

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac resynchronisation therapy: the role of the defibrillator
thumbnail
Congress Presentation
CRT is preferred pacing option
thumbnail
Congress Presentation
CRT should be recommended for all heart failure patients with mechanical dyssynchrony and a ventricular conduction delay regardless of the QRS morphology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources